Netpharm Consulting ApS: Financial statements 2022
CVR: 41104554
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Netpharm Consulting ApS (CVR 41104554) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -10,057 compared with DKK 200 the year before. Equity in the 2022 report amounted to DKK 67,801. The solvency ratio was 100%.
- Profit/Loss
- DKK -10,057
- Equity
- DKK 67,801
- Total Assets
- DKK 67,801
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | -10K | 68K | - |
| 2021 | 153K | 200 | 200 | 78K | - |
| 2020 | 0 | -12K | -12K | 28K | - |
Official annual report
Keep an eye on Netpharm Consulting ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Netpharm Consulting ApS has published its annual report for 2021. Revenue came to DKK 152,564, and the net result was DKK 200.
About Netpharm Consulting ApS
Netpharm Consulting ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Byong Sandersen. The company is owned by Netpharm Holding ApS. According to the 2024 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -18,341 and a net result of DKK -18,341 compared with DKK -14,288 the year before. Equity in the 2025 report amounted to DKK 15,365.